These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 34530063)

  • 1. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
    Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
    J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.
    Ariza X; Graupera I; Coll M; Solà E; Barreto R; García E; Moreira R; Elia C; Morales-Ruiz M; Llopis M; Huelin P; Solé C; Fabrellas N; Weiss E; Nevens F; Gerbes A; Trebicka J; Saliba F; Fondevila C; Hernández-Gea V; Fernández J; Bernardi M; Arroyo V; Jiménez W; Deulofeu C; Pavesi M; Angeli P; Jalan R; Moreau R; Sancho-Bru P; Ginès P;
    J Hepatol; 2016 Jul; 65(1):57-65. PubMed ID: 26988732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis.
    Jiang QQ; Han MF; Ma K; Chen G; Wan XY; Kilonzo SB; Wu WY; Wang YL; You J; Ning Q
    World J Gastroenterol; 2018 Jun; 24(21):2300-2310. PubMed ID: 29881239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of urinary liver-type fatty acid-binding protein in critically ill patients.
    Cho E; Yang HN; Jo SK; Cho WY; Kim HK
    J Korean Med Sci; 2013 Jan; 28(1):100-5. PubMed ID: 23341719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil gelatinase-associated lipocalin and liver-type fatty acid-binding protein as biomarkers for acute kidney injury after organ transplantation.
    Iguchi N; Uchiyama A; Ueta K; Sawa Y; Fujino Y
    J Anesth; 2015 Apr; 29(2):249-55. PubMed ID: 25205293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
    Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
    J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
    Naruse H; Ishii J; Takahashi H; Kitagawa F; Nishimura H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Hayashi M; Sarai M; Watanabe E; Izawa H; Ozaki Y
    Crit Care; 2018 Aug; 22(1):197. PubMed ID: 30119691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sTREM-1 as promising prognostic biomarker for acute-on-chronic liver failure and mortality in patients with acute decompensation of cirrhosis.
    Yu SM; Li H; Deng GH; Wang XB; Zheng X; Chen JJ; Meng ZJ; Zheng YB; Gao YH; Qian ZP; Liu F; Lu XB; Shi Y; Shang J; Chen RC; Huang Y
    World J Gastroenterol; 2024 Mar; 30(9):1177-1188. PubMed ID: 38577193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte Fatty Acid-Binding Protein as a Predictor of Outcome in Alcohol-induced Acute-On-Chronic Liver Failure.
    Kulkarni AV; Sharma M; Kumar P; Simhadri V; Sowmya TR; Mitnala S; Nageshwar Reddy D; Nagaraja Rao P
    J Clin Exp Hepatol; 2021; 11(2):201-208. PubMed ID: 33746445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.
    Markwardt D; Holdt L; Steib C; Benesic A; Bendtsen F; Bernardi M; Moreau R; Teupser D; Wendon J; Nevens F; Trebicka J; Garcia E; Pavesi M; Arroyo V; Gerbes AL
    Hepatology; 2017 Oct; 66(4):1232-1241. PubMed ID: 28545169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum NGAL Is Superior to Cystatin C in Predicting the Prognosis of Acute-on-Chronic Liver Failure.
    Lu J; Lin L; Ye C; Tao Q; Cui M; Zheng S; Zhu D; Liu L; Xue Y
    Ann Hepatol; 2019; 18(1):155-164. PubMed ID: 31113585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure.
    Trieb M; Rainer F; Stadlbauer V; Douschan P; Horvath A; Binder L; Trakaki A; Knuplez E; Scharnagl H; Stojakovic T; Heinemann Á; Mandorfer M; Paternostro R; Reiberger T; Pitarch C; Amorós A; Gerbes A; Caraceni P; Alessandria C; Moreau R; Clària J; Marsche G; Stauber RE
    J Hepatol; 2020 Jul; 73(1):113-120. PubMed ID: 32061870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
    Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP
    Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V;
    J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
    J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis.
    Wang T; Tan W; Wang X; Zheng X; Huang Y; Li B; Meng Z; Gao Y; Qian Z; Liu F; Lu X; Yan H; Zheng Y; Zhang W; Yin S; Gu W; Zhang Y; Dong F; Wei J; Deng G; Xiang X; Zhou Y; Hou Y; Zhang Q; Xiong S; Liu J; Long L; Chen R; Chen J; Jiang X; Luo S; Chen Y; Jiang C; Zhao J; Ji L; Mei X; Li J; Li T; Zheng R; Zhou X; Ren H; Shi Y; Li H;
    JHEP Rep; 2022 Oct; 4(10):100529. PubMed ID: 36052222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.
    Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M
    J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.